Piet Ost
Impact in
- Pulmonary and Respiratory Medicine top 0.1%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Cancer Research top 1%
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
-
- Prostate Cancer Diagnosis and Treatment 142
- Prostate Cancer Treatment and Research 116
-
- Radiopharmaceutical Chemistry and Applications 27
- Co-authors
- Gert De Meerleer (63 shared papers)Valérie Fonteyne (83 shared papers)Karel Decaestecker (57 shared papers)Nicolaas Lumen (58 shared papers)Geert M. Villeirs (32 shared papers)Bertrand F. TOMBAL (6 shared papers)Bieke Lambert (12 shared papers)Louke J. Delrue (13 shared papers)
- Journals
- European Urology (39 papers)Radiotherapy and Oncology (30 papers)International Journal of Radiation Oncology*Biology*Physics (25 papers)European Urology Oncology (16 papers)European Urology Focus (15 papers)
- Partner nations
- BelgiumItalyUnited States
In The Last Decade
Piet Ost
315 papers receiving 13.9k citations
Piet Ost's Hit Papers
Peers
Comparison fields: 5 of 139
- Pulmonary and Respiratory Medicine 8.4k
- Cancer Research 1.6k
- Radiation 926
- Radiology, Nuclear Medicine and Imaging 1.9k
- Oncology 1.8k
Countries citing papers authored by Piet Ost
This map shows the geographic impact of Piet Ost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piet Ost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piet Ost more than expected).
Fields of papers citing papers by Piet Ost
This network shows the impact of papers produced by Piet Ost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piet Ost. The network helps show where Piet Ost may publish in the future.
Co-authors
The 25 scholars most cited alongside Piet Ost, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 332 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial Hit paper breakdown → | 2017 | 1017 |
| 2 | Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation Hit paper breakdown → | 2020 | 796 |
| 3 | Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Hit paper breakdown → | 2020 | 704 |
| 4 | Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci Hit paper breakdown → | 2018 | 623 |
| 5 | Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 Hit paper breakdown → | 2017 | 554 |
| 6 | Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction Hit paper breakdown → | 2021 | 317 |
| 7 | 2020 | 302 | |
| 8 | 2014 | 290 | |
| 9 | 2015 | 238 | |
| 10 | 2014 | 225 | |
| 11 | 2014 | 219 | |
| 12 | Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials Hit paper breakdown → | 2022 | 186 |
| 13 | 2012 | 166 | |
| 14 | 2020 | 151 | |
| 15 | 2018 | 148 | |
| 16 | 2017 | 140 | |
| 17 | 2021 | 135 | |
| 18 | 2020 | 131 | |
| 19 | Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 Hit paper breakdown → | 2023 | 125 |
| 20 | Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium Hit paper breakdown → | 2023 | 121 |
About Piet Ost
Piet Ost is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Cancer Research, Radiation and Oncology, having authored 332 papers that have together received 14.1k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (142 papers), Prostate Cancer Treatment and Research (116 papers), Radiopharmaceutical Chemistry and Applications (27 papers), Bladder and Urothelial Cancer Treatments (27 papers), Advanced Radiotherapy Techniques (22 papers), Cancer Immunotherapy and Biomarkers (15 papers), Cancer, Lipids, and Metabolism (14 papers) and Cancer Genomics and Diagnostics (12 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (8.4k citations), Cancer Research (1.6k citations), Radiation (926 citations), Radiology, Nuclear Medicine and Imaging (1.9k citations) and Oncology (1.8k citations). Piet Ost has collaborated with scholars based in Belgium, Italy and United States. Frequent co-authors include Gert De Meerleer, Valérie Fonteyne, Karel Decaestecker, Nicolaas Lumen, Geert M. Villeirs, Bertrand F. TOMBAL, Bieke Lambert, Louke J. Delrue, Alberto Briganti and Silke Gillessen. Their work appears in journals such as European Urology, Radiotherapy and Oncology, International Journal of Radiation Oncology*Biology*Physics, European Urology Oncology and European Urology Focus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.